Intrinsic Value of S&P & Nasdaq Contact Us

Omeros Corporation OMER NASDAQ

NASDAQ Global Market • Healthcare • Biotechnology • US • USD

SharesGrow Score
48/100
2/6 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$40.00
+237.8%
SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

Omeros Corporation (OMER) has a negative trailing P/E of -220.9, meaning the company is currently unprofitable on a trailing twelve-month (TTM) basis. The forward P/E of 14.5 based on analyst estimates suggests a return to profitability is expected. Trailing earnings yield is -0.45%, forward earnings yield 6.91%. PEG 0.17 (Peter Lynch undervalued ≤1.0).

Criteria proven by this page:

  • VALUE (100/100, Pass) — PEG ≤ 1.0 — Peter Lynch undervalued (0.17); analyst target implies upside (+237.8%).
  • Forward P/E 14.5 — analysts expect a return to profitability with estimated EPS of $0.82 for FY2027.
  • PEG Ratio 0.17 — below 1.0 suggests the stock is undervalued relative to its earnings growth rate (Peter Lynch criterion).
  • Trailing Earnings Yield -0.45% — negative yield confirms the company is currently unprofitable. Investors are paying for a turnaround rather than current earnings. Forward yield improves to 6.91% as earnings recover.
  • Analyst consensus target $40.00 (+237.8% upside) — significant upside potential according to Wall Street analysts.

Overall SharesGrow Score: 47/100 with 2/7 criteria passed.

SharesGrow 7-Criteria Score
48/100
SG Score
View full scorecard →
VALUE
100/100
Price-to-Earnings & upside
Proven by this page
FUTURE
64/100
Analyst consensus
→ Forecast
PAST
25/100
→ Income
~
HEALTH
50/100
Debt-to-Equity & liquidity
→ Health
MOAT
34/100
→ Income
GROWTH
15/100
→ Income
INCOME
N/A
No coverage

Valuation Snapshot — OMER

Valuation Multiples
P/E (TTM)-220.9
Forward P/E14.5
PEG Ratio0.17
Forward PEG0.17
P/B Ratio-6.10
P/S Ratio0.00
EV/EBITDA-9.7
Per Share Data
EPS (TTM)$-0.05
Forward EPS (Est.)$0.82
Book Value / Share$-1.91
Revenue / Share$0.00
FCF / Share$-1.83
Yields & Fair Value
Earnings Yield-0.45%
Forward Earnings Yield6.91%
Dividend Yield0.00%
Analyst Target$40.00 (+237.8%)

Historical Valuation

Year P/E (TTM) PEG Ratio P/B Ratio P/S Ratio Dividend Yield
2016 -6.0 0.34 -10.71 9.64 -
2017 -16.5 0.57 -314.44 13.65 -
2018 -4.3 -0.03 0.83 18.12 -
2019 -8.3 0.48 -6.40 6.24 -
2020 -5.9 -0.51 -6.77 0.00 -
2021 -3.6 0.02 16.86 0.00 -
2022 3.0 -0.04 1.65 0.00 -
2023 -1.7 0.00 -8.21 0.00 -
2024 -3.7 -0.08 -3.15 0.00 -
2025 -325.7 3.32 -9.00 0.00 -

EPS: Actual vs Estimates

P/E Ratio & Earnings Yield

Earnings Per Share (EPS) History

Year EPS (Diluted) Revenue Net Income Net Margin
2016 $-1.65 $41.62M $-66.75M -160.4%
2017 $-1.17 $64.83M $-53.48M -82.5%
2018 $-2.61 $29.87M $-126.76M -424.4%
2019 $-2.16 $111.81M $-106.91M -95.6%
2020 $-2.41 $73.81M $-138.06M -187%
2021 $3.12 $0.00 $194.24M -
2022 $0.46 $0.00 $28.78M -
2023 $-1.88 $0.00 $-117.81M -
2024 $-2.70 $0.00 $-156.82M -
2025 $-0.05 $0.00 $-3.35M -

Analyst Estimates

Year EPS (Avg) EPS Range Revenue (Avg) Revenue Range Analysts
2026 $-0.53 $-1.13 – $-0.26 $115.8M $69.96M – $215.96M 1
2027 $0.44 $0.21 – $0.93 $241.34M $145.8M – $450.07M 2
2028 $2.34 $1.13 – $4.96 $436.33M $263.6M – $813.71M 1
2029 $3.86 $1.87 – $8.21 $639.19M $386.14M – $1.19B 1
2030 $5.00 $2.43 – $10.62 $799.02M $482.7M – $1.49B 1
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message